# LENALIDOMIDE
> **ANDA213405** · Abbreviated New Drug Application (Generic) · Sponsor: TORRENT · Approved 2023-08-03
## Drug
- **FDA Application Number:** ANDA213405
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LENALIDOMIDE
- **Generic name:** Lenalidomide
- **Active ingredients:** LENALIDOMIDE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** TORRENT
- **First approval:** 2023-08-03
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213405)
---
*MORVS · CC0 1.0*